Skip to main content
Clinical Trials/NCT04601896
NCT04601896
Completed
Not Applicable

Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018

University Hospital, Grenoble1 site in 1 country75 target enrollmentOctober 16, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractory Cardiac Arrest
Sponsor
University Hospital, Grenoble
Enrollment
75
Locations
1
Primary Endpoint
Global quality of life score
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

If the ExtraCorporeal Membrane Oxygenation (ECMO) improves survival in the management of refractory cardiac arrest (RCA), this technique is still an invasive technique, not devoid of complications and requiring intensive care that can have serious consequences for patients. If the studies so far show an acceptable quality of life post ECMO in refractory cardiac arrest, the study looks about the quality of life of our patients in Grenoble who survived a refractory cardiac arrest between 2006 and 2018 at the hospital university Grenoble Alps and the factors influencing this quality of life.

Registry
clinicaltrials.gov
Start Date
October 16, 2020
End Date
April 27, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Grenoble
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult \>18 years
  • Admission to intensive care unit after a Refractory Cardiac Arrest
  • Hemodynamic instability after resumption of spontaneous cardiac activity.
  • Non-opposition of the patient or his relatives
  • Admission to intensive care unit From 2006 Through 2018

Exclusion Criteria

  • ECMO for hypothermia or drug intoxication.
  • Comorbidity contraindicated the ECMO
  • Patients dead before hospital discharge

Outcomes

Primary Outcomes

Global quality of life score

Time Frame: Through study completion, an average of 3 months

Items from the SF36 (Short Form 36) survey

Secondary Outcomes

  • Vital status(Through study completion, an average of 3 months)
  • Live patients characteristics description(Through study completion, an average of 3 months)
  • Quality of life score related at live patients characteristics description(Through study completion, an average of 3 months)
  • Quality of life score comparison(Through study completion, an average of 3 months)

Study Sites (1)

Loading locations...

Similar Trials